Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
about
Clinical review: Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patientsCardiac biomarkers: new tools for heart failure managementPhagocyte-myocyte interactions and consequences during hypoxic wound healing.Neutrophil Gelatinase Associated Lipocalin (NGAL) as a Biomarker. Does It Apply in Abdominal Aortic Aneurysms? A Review of LiteratureA lipocalin sequence signature modulates cell survival.Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome.Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference.Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome.Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.The effects of heart failure on renal function.The impairment of ILK related angiogenesis involved in cardiac maladaptation after infarction.Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review.Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts renal injury in acute decompensated cardiac failure: a prospective observational study.A novel biomarker in the diagnosis of parapneumonic effusion: neutrophil gelatinase-associated lipocalinThe cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure.Association between plasma neutrophil gelatinase associated lipocalin level and obstructive sleep apnea or nocturnal intermittent hypoxiaNeutrophil gelatinase-associated lipocalin and cystatin C for the prediction of clinical events in patients with advanced heart failure and after ventricular assist device placement.Inflammation and ER stress downregulate BDH2 expression and dysregulate intracellular iron in macrophages.Emerging biomarkers in heart failure and cardiac cachexiaNeutrophil gelatinase-associated lipocalin in the diagnosis of type 1 cardio-renal syndrome in the general ward.A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancerRenal dysfunction is a stronger determinant of systemic neutrophil gelatinase-associated lipocalin levels than myocardial dysfunction in systolic heart failureImproving prognosis estimation in patients with heart failure and the cardiorenal syndromeThe role of urine neutrophil gelatinase--associated lipocalin (NGAL) in acute heart failure in patients with ST--elevation myocardial infarction.Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition.Improved functional recovery to I/R injury in hearts from lipocalin-2 deficiency mice: restoration of mitochondrial function and phospholipids remodelingLipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation.Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.Small lipid-binding proteins in regulating endothelial and vascular functions: focusing on adipocyte fatty acid binding protein and lipocalin-2.The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancerPlasma Levels of Monocyte Chemoattractant Protein-1, n-Terminal Fragment of Brain Natriuretic Peptide and Calcidiol Are Independently Associated with the Complexity of Coronary Artery Disease.Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure.Prognostic impact of neutrophil gelatinase-associated lipocalin and B-type natriuretic in patients with ST-elevation myocardial infarction treated by primary PCI: a prospective observational cohort studyPlasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney DiseaseUrinary neutrophil gelatinase-associated lipocalin time course during cardiac surgery.Cardiorenal syndrome type 4: a reviewAcute heart failure: patient characteristics and pathophysiology.Associations Between Neutrophil Gelatinase Associated Lipocalin, Neutrophil-to-Lymphocyte Ratio, Atrial Fibrillation and Renal Dysfunction in Chronic Heart Failure.Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts.Transcriptomic effects of adenosine 2A receptor deletion in healthy and endotoxemic murine myocardium.
P2860
Q26852689-B1C0D158-D0CB-4E90-A73D-35883B35F982Q26991726-F8C41138-3864-4F18-A9D7-707A584E9C45Q27690914-319710B7-C657-4B35-9497-7956D8EBBA6DQ28074360-CF8943EE-D353-400E-B11A-3488F8A48DC6Q30156855-1CB70048-2381-4167-AC38-06709E1A62D0Q30404049-CC3ACABF-8600-4470-B4AB-1E0413E0EA80Q30410183-5011C1B9-C585-4558-8021-CF7F4E9E1C7CQ33768050-2D814D76-DB71-40F2-994E-4BFC4895BEEAQ33969500-713F96B5-3EF8-41A5-B6D8-A8FF7E2B0579Q33996089-7E03B7DA-7CB4-4A7A-BA24-4E043CF8B903Q34031262-33A5ADFD-E881-4589-AE58-12DAA03627B7Q34086935-180982B1-B3C5-4014-86D3-8E7106AE4A83Q34160755-E42B8BAA-3535-4DCF-918B-1098BC49DF5EQ34217270-7D6D940B-449A-45D6-A6A1-0F3AA2FF6945Q34429191-EEE3B314-848F-4E92-86AF-09F655F90133Q34559205-D45C42A6-117F-4393-B7E2-F17E6DB378A5Q34616632-7F5F4021-FD31-4E02-AA22-31422FD4C99BQ34707217-C110948E-A615-407E-832F-73D8DFDBE57AQ34836097-A816C2B3-A257-4B8B-BD5A-CD90FB91150EQ34857517-9E93198F-9DD1-4414-823B-62D31A5A2D54Q34895774-14019C74-397E-46AA-82D0-C3920D36C385Q35017352-F47FEDDA-01F7-430C-91D3-57C71AF56A32Q35020305-609EC260-8781-40E0-9D81-E186ACBDEDA1Q35662587-60A5395B-2653-4AE8-9B7A-3C06BC8ABB83Q35708229-7ADABB41-C3B9-456F-8664-75B791BDFB6AQ35759703-1E2A9A00-C877-4287-8202-CF3831BABE2DQ35763055-CF89B2AB-EEB3-4ABF-A528-B63EF8D3945AQ35854126-BCE37E53-6015-4334-AFFF-6881A33E4B43Q35859743-2671B287-8626-4B8F-832F-612D57A2F8DCQ35996059-F15B7957-86C0-4D3A-90DF-01B717E9F7AFQ36015686-5E29557D-F2C9-4338-BF3C-3AB43ED0452DQ36093457-E7CF463F-2B15-4191-A178-5B67408FFDB9Q36163460-AE54B31A-685D-4CD5-B244-AC1698B0C4A6Q36731508-CED338F8-9AED-4A68-9AD3-48F94ECEA3B3Q36987790-78C70DE8-54E9-405E-AADC-520AD1EDD3A4Q37095187-D7170977-F179-4CE6-B1A2-4850279455B5Q37297364-DA017A70-198E-4308-A320-CDFDE4A5AF40Q37500020-22E40BDB-EF9C-41CF-8A02-DF9B0A604D1EQ37546836-692A5F5C-A1A8-4C13-BD64-7DC9CD7C7562Q37677794-B62EE7BA-80D2-4F09-B9ED-4C8975407623
P2860
Increased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failure
description
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im Mai 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/05/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/05/01)
@nl
наукова стаття, опублікована в травні 2009
@uk
مقالة علمية (نشرت في مايو 2009)
@ar
name
Increased systemic and myocard ...... and experimental heart failure
@ast
Increased systemic and myocard ...... and experimental heart failure
@en
Increased systemic and myocard ...... and experimental heart failure
@nl
type
label
Increased systemic and myocard ...... and experimental heart failure
@ast
Increased systemic and myocard ...... and experimental heart failure
@en
Increased systemic and myocard ...... and experimental heart failure
@nl
prefLabel
Increased systemic and myocard ...... and experimental heart failure
@ast
Increased systemic and myocard ...... and experimental heart failure
@en
Increased systemic and myocard ...... and experimental heart failure
@nl
P2093
P2860
P50
P3181
P356
P1476
Increased systemic and myocard ...... and experimental heart failure
@en
P2093
Cathrine Husberg
Christen P. Dahl
Leif Erik Vinge
Linn Landrø
Trude H. Flo
P2860
P304
P3181
P356
10.1093/EURHEARTJ/EHP088
P50
P577
2009-05-01T00:00:00Z